These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20164576)

  • 1. Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease.
    Daulatzai MA
    J Alzheimers Dis; 2010; 20(2):355-67. PubMed ID: 20164576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Re-)activation of neurons in aging and dementia: lessons from the hypothalamus.
    Swaab DF; Bao AM
    Exp Gerontol; 2011; 46(2-3):178-84. PubMed ID: 20833237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
    Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
    Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.
    Terry AV; Buccafusco JJ
    J Pharmacol Exp Ther; 2003 Sep; 306(3):821-7. PubMed ID: 12805474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbances in neurotransmission processes in aging and age-related diseases.
    Ossowska K
    Pol J Pharmacol; 1993; 45(2):109-31. PubMed ID: 8401765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain aging and Alzheimer's disease; use it or lose it.
    Swaab DF; Dubelaar EJ; Hofman MA; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 2002; 138():343-73. PubMed ID: 12432778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation.
    Lee CL; Kuo TF; Wang JJ; Pan TM
    J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral blood flow and recognition memory in elderly normals: potential application to Alzheimer's disease.
    Schwartz RS; Burke C; Snars J; Gordon E; Batchelor J; Kostalas G; Meares R; Yiannikas C
    Clin Exp Neurol; 1991; 28():56-65. PubMed ID: 1821840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
    Coulson EJ; May LM; Sykes AM; Hamlin AS
    Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of functional imaging of memory decline in Alzheimer's disease.
    Drzezga A
    Methods; 2008 Apr; 44(4):304-14. PubMed ID: 18374274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
    Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.